(Q36548175)

14 August 2017

Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. (English)

1 reference

14 August 2017

0 references

Shah PL

1

1 reference

14 August 2017

Scott SF

2

1 reference

14 August 2017

Fuchs HJ

3

1 reference

14 August 2017

Geddes DM

4

1 reference

14 August 2017

Hodson ME

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

14 August 2017

1 reference

14 August 2017

50

1 reference

14 August 2017

4

1 reference

14 August 2017

333-338

1 reference

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474268

Cystic fibrosis in adolescents and adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474268

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474268

A new prognostic score and clinical evaluation system for cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474268

Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474268

The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474268

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

21 September 2018

1 reference

12 December 2020

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

1 reference

12 December 2020

Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis

1 reference

12 December 2020

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis

1 reference

12 December 2020

Bronchospasm after inhalation of pancreatic dornase

1 reference

12 December 2020

Validation of a vertical visual analogue scale as a measure of clinical dyspnea

1 reference

12 December 2020

The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum

1 reference

12 December 2020

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.50.4.333

1 reference

14 August 2017

1 reference

14 August 2017

1 reference